Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Biomarker-guided reduction of antibiotic duration in hospitalized community-acquired pneumonia
NL-OMON45194Active, not recruiting
- Sponsor
- Noordwest Ziekenhuisgroep
- Start
- Dec 2013
- Countries
- 1
01
Overview
Open-label trial in community-acquired pneumonia (CAP) and pneumonia (3 arms), sponsored by Noordwest Ziekenhuisgroep. Primary endpoint: Duration of antibiotic treatment. Started Dec 2013; status: active, not recruiting.
02
Conditions
community-acquired pneumonia (CAP)pneumonia
Beyond the preview
Go deeper on NL-OMON45194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON45194.